Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals

计划入组 186 人 · 首次发布于 2019 年 7 月 30 日

Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients

计划入组 84 人 · 首次发布于 2019 年 5 月 31 日

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

计划入组 42 人 · 首次发布于 2007 年 1 月 25 日

Tuvirumab

Hepatitis B Vaccine (Recombinant)(Engerix-B, Heplisav-B, Pediarix, Recombivax, Twinrix, Vaxelis, Heplisav B, Fendrix, PreHevbri, Twinrix Paediatric, Hexacima, Twinrix Adult, Ambirix, Hexyon, Infanrix Hexa)

hepatitis B virus vaccine

ANTIGEN LABORATORIES INC.

United States

Hepatitis Resource Network

United States

SURFACE LOGIX, INC.

United States

Bluejay Therapeutics' BJT-778 Demonstrates 100% Virologic Response in Hepatitis D Phase 2 Trial

Gilead Presents Three-Year Livdelzi Data Showing Liver Health Stabilization in Primary Biliary Cholangitis Patients

Phase 1 Trial Launches for Novel Hepatitis B Antibody Treatment GIGA-2339